This page shows the latest inflammatory conditions news and features for those working in and with pharma, biotech and healthcare.
indicated for a variety of other inflammatory conditions over the years.
The drug has already been on the US market for more than two decades for the treatment of rheumatoid arthritis, and has been indicated for a variety of other inflammatory conditions ... as well as a variety of inflammatory conditions.
This latest agreement is the second between the two companies and expands on the first multi-target discovery deal signed in June 2020, which focuses on autoimmune and inflammatory disease areas. ... According to the conditions of the new agreement,
The multi-target research and development partnership will focus on severe, chronic skin diseases, including immune-mediated inflammatory conditions such as atopic dermatitis and non-melanoma skin cancer such as basal
She added: “Working with the MHRA to bring risankizumab to eligible people with Crohn’s disease reflects our ambition to bring innovative medicines to people with debilitating conditions like inflammatory bowel
Atopic dermatitis is one of the most common inflammatory skin conditions – affecting around 5-10% of adults living in the US, while 1 in 3 suffer with moderate-to-severe symptoms – ... Mike Gladstone, global president of Pfizer Inflammation
More from news
Approximately 0 fully matching, plus 46 partially matching documents found.
However, we must not neglect the fact that, for non-COVID patients, many people have faced delays and cancellations for the treatment of debilitating conditions, such as Inflammatory Bowel Disease (IBD) ... With a focus on inflammatory and fibrotic
conditions. 2. AR101 – the first peanut allergy treatment. Potentially deadly allergies to food and other everyday substances are on the rise around the world – and there are currently very few therapies ... Boehringer Ingelheim) for psoriatic
49. Mesoblast / Celgene. Minority investment and option to license. stem-cell product candidates for conditions including inflammatory bowel disease and certain oncological indications.
Celgene, will gain six months right of first refusal on Mesoblast's stem-cell product candidates for conditions including inflammatory bowel disease and certain oncological indications, for global rights (excluding Japan),
7, 100. Questcor/ Mallinckrodt. Acquisition. Acthar Gel (repository corticotropin) for “difficult-to-treat” autoimmune/ inflammatory conditions.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
In this role, Genovese will oversee the clinical development of Gilead’s investigational portfolio of treatments for inflammatory conditions.
She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.
research into immunotherapies for cancer and inflammatory diseases. ... He is familiar with Innate through its collaboration with Novo on immunotherapies, including IPH2201, a monoclonal antibody targeting NKG2A in development to treat patients with
Idera specialises in developing toll-like receptors (TLRs) for autoimmune and inflammatory conditions and will benefit from Geraghty's extensive career in the life sciences industry, which includes 20 years ion ... conditions. 19th July 2013.
and autoimmune conditions. ... multiple sclerosis and secukinumab for several inflammatory conditions.
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
November 10, 2021, UK.Fishawack Health, the leading commercialization partner for the life science industry, welcomes FIDE to its group—an independent expert-led consultancy specializing in chronic inflammatory skin conditions ... Fishawack Health’s
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...